🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Cliff Asness’s ICUI Holdings & Trades

First Buy
Q4 2012
Duration Held
50 Quarters
Largest Add
Q3 2018
+324,819 Shares
Current Position
15,263 Shares
$1.97 M Value

Cliff Asness's ICUI Position Overview

Cliff Asness (via Aqr Capital Management LLC) currently holds 15,263 shares of ICU Medical, Inc. (ICUI) worth $1.97 M, representing 0.00% of the portfolio. First purchased in 2012-Q4, this long-term strategic position has been held for 50 quarters.

Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in ICUI, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2018, adding 324,819 shares. Largest reduction occurred in Q2 2019, reducing 139,031 shares.

Analysis based on 13F filings available since 2013 Q2

Cliff Asness's ICU Medical (ICUI) Holding Value Over Time

Track share changes against reported price movement

Quarterly ICU Medical (ICUI) Trades by Cliff Asness

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q1 2026 +5,714 Add 59.84% 15,263 $129.15
Q4 2025 +808 Add 9.24% 9,549 $142.67
Q3 2025 +166 Add 1.94% 8,741 $119.96
Q2 2025 -785 Reduce 8.39% 8,575 $132.15
Q1 2025 +229 Add 2.51% 9,360 $138.54
Q4 2024 +1,623 Add 21.62% 9,131 $155.17
Q3 2024 -21,125 Reduce 73.78% 7,508 $182.22
Q2 2024 -4,690 Reduce 14.07% 28,633 $118.75
Q1 2024 +33,323 New Buy 33,323 $104.17
Q4 2022 -1,540 Sold Out 0 $0.00
Q3 2022 -43,156 Reduce 96.55% 1,540 $150.65
Q2 2022 -51,169 Reduce 53.38% 44,696 $164.40
Q1 2022 +16,026 Add 20.07% 95,865 $222.64
Q4 2021 +7,784 Add 10.80% 79,839 $237.34
Q3 2021 -3,268 Reduce 4.34% 72,055 $233.38
Q2 2021 -17,047 Reduce 18.46% 75,323 $203.27
Q1 2021 +14,701 Add 18.93% 92,370 $205.43
Q4 2020 -7,751 Reduce 9.07% 77,669 $213.19
Q3 2020 +29,143 Add 51.78% 85,420 $182.76
Q2 2020 +7,211 Add 14.70% 56,277 $181.00
Q1 2020 -34,352 Reduce 41.18% 49,066 $196.55
Q4 2019 -25,049 Reduce 23.09% 83,418 $186.12
Q3 2019 -105,791 Reduce 49.38% 108,467 $157.60
Q2 2019 -139,031 Reduce 39.35% 214,258 $250.81
Q1 2019 -28,340 Reduce 7.43% 353,289 $238.86
Q4 2018 -550 Reduce 0.14% 381,629 $229.63
Q3 2018 +324,819 Add 566.28% 382,179 $282.75
Q2 2018 +47,658 Add 491.22% 57,360 $294.23
Q1 2018 +2,070 Add 27.12% 9,702 $252.32
Q4 2017 +396 Add 5.47% 7,632 $216.06
Q3 2017 -277 Reduce 3.69% 7,236 $185.88
Q2 2017 +739 Add 10.91% 7,513 $172.50
Q1 2017 +293 Add 4.52% 6,774 $152.64
Q4 2016 -6,965 Reduce 51.80% 6,481 $147.35
Q3 2016 -15,489 Reduce 53.53% 13,446 $126.36
Q2 2016 -7,143 Reduce 19.80% 28,935 $112.74
Q1 2016 -8,039 Reduce 18.22% 36,078 $104.11
Q4 2015 -17,946 Reduce 28.92% 44,117 $112.77
Q3 2015 -7,869 Reduce 11.25% 62,063 $109.50
Q2 2015 +2,033 Add 2.99% 69,932 $95.66
Q1 2015 +23,040 Add 51.36% 67,899 $93.14
Q4 2014 +13,700 Add 43.97% 44,859 $81.90
Q3 2014 -26,300 Reduce 45.77% 31,159 $64.19
Q2 2014 -89,500 Reduce 60.90% 57,459 $60.81
Q1 2014 +18,200 Add 14.13% 146,959 $59.88
Q4 2013 -12,329 Reduce 8.74% 128,759 $63.71
Q3 2013 -2,300 Reduce 1.60% 141,088 $67.93
Q2 2013 +143,388 Add 0.00% 143,388 $72.06
Q4 2012 +145,336 Add 0.00% 145,336 $60.93

Cliff Asness's ICU Medical Investment FAQs

Cliff Asness first purchased ICU Medical, Inc. (ICUI) in Q4 2012, acquiring 145,336 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness has held ICU Medical, Inc. (ICUI) for 50 quarters since Q4 2012.

Cliff Asness's largest addition to ICU Medical, Inc. (ICUI) was in Q3 2018, adding 382,179 shares worth $108.06 M.

According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 15,263 shares of ICU Medical, Inc. (ICUI), valued at approximately $1.97 M.

As of the Q1 2026 filing, ICU Medical, Inc. (ICUI) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.

Cliff Asness's peak holding in ICU Medical, Inc. (ICUI) was 382,179 shares, as reported at the end of Q3 2018.